These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DELAWARE
|
333-29295
|
30-0957912
|
|
(State of incorporation)
|
(Commission File No.)
|
(I.R.S. Identification Number
|
|
|
|
Former name, former address, and former fiscal year, if changed since last report
|
|
Large accelerated filer [_]
|
|
Accelerated filer [_]
|
|
Non-accelerated filer [_] (Do not check if a smaller reporting company)
|
|
Smaller reporting company [X]
|
| Emerging growth company [_] |
|
|
|
||||
|
|
|
Page
|
|
||
|
Financial Statements
|
|
|
|||
|
|
Balance Sheets as of September 30, 2017 (unaudited)
|
|
|
3
|
|
|
Statements of Operations (unaudited) for the nine months ended September 30, 2017
|
|
|
4
|
|
|
| Statement of Stockholders' Equity (unaudited) for the nine months ended September 30, 2017 | 5 | ||||
|
|
Statements of Cash Flows (unaudited) for the nine months ended September 30, 2017
|
|
|
6
|
|
|
|
Notes to Financial Statements (unaudited)
|
|
|
8
|
|
|
Management's Discussion and Analysis or Plan of Operation
|
|
|
16
|
|
|
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
|
23
|
|
|
|
Controls and Procedures
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal Proceedings
|
|
|
24
|
|
|
|
Risk Factors
|
|
|
24
|
|
|
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
24
|
|
|
|
Defaults Upon Senior Securities
|
|
|
24
|
|
|
|
Mine Safety Disclosures
|
|
|
24
|
|
|
|
Other Information
|
|
|
24
|
|
|
|
Exhibits
|
|
|
24
|
|
|
|
|
|
25
|
|
||
|
|
||||||||
|
September 30, 2017
|
December 31, 2016
|
|||||||
| (Unaudited) | (Audited) | |||||||
|
ASSETS
|
||||||||
|
Current Assets:
|
||||||||
|
Cash
|
$
|
41,929
|
$
|
10,116
|
||||
|
Accounts receivable
|
272,879
|
-
|
||||||
|
Vendor notes receivable, net of allowance for doubtful
|
-
|
2,585,000
|
||||||
|
collection of $360,993
|
-
|
-
|
||||||
|
Vendor advances receivable
|
-
|
89,934
|
||||||
|
Inventories, at lower cost or market, principally average cost method
|
1,608,394
|
219,105
|
||||||
|
Prepaid expense
|
258,804
|
-
|
||||||
|
Total Current Assets
|
2,182,006
|
2,904,155
|
||||||
|
Equipment,
net of accumulated depreciation of $54,981 at September 30, 2017
|
528,321
|
-
|
||||||
|
Other Assets:
|
||||||||
|
Licensing agreements, net of $33,333 of accumulated amortization in 2017
|
216,667
|
125,000
|
||||||
|
Patents, net of $5,278 of accumulated amortization in 2017
|
944,722
|
-
|
||||||
|
TOTAL ASSETS
|
$
|
3,871,716
|
$
|
3,029,155
|
||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
Current Liabilities:
|
||||||||
|
Accounts payable
|
$
|
394,692
|
$
|
57,995
|
||||
|
Related party payable
|
95,636
|
|||||||
|
Accrued liabilities
|
126,681
|
-
|
||||||
|
Convertible note payable, net of debt discount of $356,250 in 2016
|
1,775,000
|
1,518,750
|
||||||
|
Note payable - related party
|
426,837
|
960,000
|
||||||
|
Insurance premium note payable
|
40,466
|
-
|
||||||
|
Total Current Liabilities
|
2,859,312
|
2,536,745
|
||||||
|
Shareholders' Equity:
|
||||||||
|
Common Stock, $0.001 par value, 100,000,000 shares authorized
|
||||||||
|
20,300,621 and 15,754,000 shares issued and outstanding at
|
||||||||
|
September 30, 2017 and December 31, 2016, respectively
|
20,301
|
15,754
|
||||||
|
Additional paid-in capital
|
5,039,571
|
799,180
|
||||||
|
Stock subscription receivable
|
-
|
(167,500
|
)
|
|||||
|
Accumulated (Deficit)
|
(4,047,468
|
)
|
(155,024
|
)
|
||||
|
Total Shareholders' Equity
|
1,012,404
|
492,410
|
||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$
|
3,871,716
|
$
|
3,029,155
|
||||
|
|
||||||||
|
2017
|
2016
|
|||||||
|
(3 months)
|
(9 months)
|
|||||||
|
Gross Sales
|
$
|
152,612
|
$
|
1,123,154
|
||||
|
Customer incentives, discounts, returns, and allowances
|
- |
(1,179
|
)
|
|||||
|
Net sales
|
152,612
|
1,121,975
|
||||||
|
Cost of Goods Sold, includes depreciation and amortization of $52,408 and
|
||||||||
|
$89,014 for the three and nine ended September 30, 2017, respectively
|
99,119
|
868,773
|
||||||
|
Gross Margin
|
53,493
|
253,202
|
||||||
|
Operating Expenses
|
||||||||
|
Selling and marketing
|
120,404
|
508,138
|
||||||
|
Corporate general and administrative
|
282,185
|
1,238,234
|
||||||
|
Employee salaries and related expenses
|
193,519
|
511,594
|
||||||
|
Depreciation expense
|
1,909
|
4,578
|
||||||
|
Total operating expenses
|
598,017
|
2,262,544
|
||||||
|
Loss from Operations
|
(544,524
|
)
|
(2,009,342
|
)
|
||||
|
Other Income (Expenses)
|
||||||||
|
Loss on vendor notes receivable collectibility
|
-
|
1,414,921
|
||||||
|
Interest expense
|
24,261
|
468,182
|
||||||
|
Profit (Loss) before Income Taxes
|
(568,785
|
)
|
(3,892,444
|
)
|
||||
|
Provision for Income Taxes
|
||||||||
|
Net Profit (Loss)
|
$
|
(568,785
|
)
|
$
|
(3,892,444
|
)
|
||
|
Loss per share
|
||||||||
|
Basic and fully diluted:
|
||||||||
|
Weighted average number of shares outstanding
|
19,484,094
|
18,303,758
|
||||||
|
Loss per share
|
$
|
(0.03
|
)
|
$
|
(0.21
|
)
|
||
|
|
||||||||||||||||||||||||
|
Common Shares
|
Additional Paid-In
|
Subscription
|
Accumulated
|
|
||||||||||||||||||||
|
Number
|
Par Value
|
Capital | Receivable | (Deficit) | Total | |||||||||||||||||||
|
Balance as of January 1, 2017
|
15,754,000
|
$
|
15,754
|
$
|
799,180
|
$
|
(167,500
|
)
|
$
|
(155,024
|
)
|
$
|
492,410
|
|||||||||||
|
Reverse merger and recapitalization
|
604,321
|
604
|
(604
|
)
|
- | - |
-
|
|||||||||||||||||
|
Subscriptions collected
|
- | - | - |
167,500
|
- |
167,500
|
||||||||||||||||||
|
Common stock issued for founder shares
|
555,000
|
555
|
70
|
- | - |
625
|
||||||||||||||||||
|
Common stock issued for cash @ $1.25 per share
|
2,343,700
|
2,344
|
2,927,281
|
- | - |
2,929,625
|
||||||||||||||||||
|
Organizational costs
|
20,000
|
20
|
(17,020
|
)
|
- | - |
(17,000
|
)
|
||||||||||||||||
|
Common stock issued for payment of legal fees @ $2.50 per share
|
49,600
|
50
|
123,950
|
- | - |
124,000
|
||||||||||||||||||
|
Licensing agreement
|
100,000
|
100
|
124,900
|
- | - |
125,000
|
||||||||||||||||||
|
Legal and advisory fees
|
249,000
|
249
|
255,001
|
- | - |
255,250
|
||||||||||||||||||
|
Employee stock awards
|
25,000
|
25
|
31,225
|
- | - |
31,250
|
||||||||||||||||||
|
Shares issued for patents
|
600,000
|
600
|
749,400
|
- | - |
750,000
|
||||||||||||||||||
|
Issuance of warrants
|
- | - |
46,188
|
- | - |
46,188
|
||||||||||||||||||
|
Net loss for period ended September 30, 2017
|
- | - | - | - |
(3,892,444
|
)
|
(3,892,444
|
)
|
||||||||||||||||
|
Balance as of September 30, 2017
|
20,300,621
|
$
|
20,301
|
$
|
5,039,571
|
$
|
-
|
$
|
(4,047,468
|
)
|
$
|
1,012,404
|
||||||||||||
|
2017
|
||||
|
Cash flows from operating activities:
|
||||
|
Net (Loss)
|
$
|
(3,892,444
|
)
|
|
|
Adjustments to reconcile Net (Loss) to Net Cash provided by operations:
|
||||
|
Debt discount amortization
|
356,250
|
|||
|
Depreciation and amortization
|
93,592
|
|||
|
Uncollectible vendor notes receivable
|
1,414,921
|
|||
|
Common stock issued for legal services
|
186,500
|
|||
|
Changes in Current Assets and Liabilities
|
||||
|
Vendor advances receivable
|
186,486
|
|||
|
Accounts receivable
|
(250,077
|
)
|
||
|
Inventories
|
(879,841
|
)
|
||
|
Prepaid expenses
|
192,144
|
|||
|
Accounts payable
|
336,697
|
|||
|
Accrued liabilities
|
126,681
|
|||
|
Related party payable
|
95,636
|
|||
|
Net cash used in operating activities
|
(2,033,455
|
)
|
||
|
Cash flows from investing activities
|
||||
|
Purchase of equipment
|
(40,187
|
)
|
||
|
Net cash used in investing activities
|
(40,187
|
)
|
||
|
Cash flow from financing activities
|
||||
|
Convertible note payment
|
(100,000
|
)
|
||
|
Note payment - related party
|
(735,000
|
)
|
||
|
Insurance premium note payment
|
(140,295
|
)
|
||
|
Sale of common stock
|
3,097,750
|
|||
|
Organization and fundraising costs
|
(17,000
|
)
|
||
|
Net cash provided by financing activities
|
2,105,455
|
|||
|
Net increase in cash
|
31,813
|
|||
|
Cash, beginning of period
|
10,116
|
|||
|
Cash, end of period
|
$
|
41,929
|
||
|
Supplemental cash flow disclosures
|
||||
|
Cash paid during the period for -
|
||||
|
Interest
|
$
|
7,842
|
||
|
Income taxes
|
$
|
-
|
||
|
Non-cash investing and financing activities:
|
||||
|
Vendor note receivable foreclosure -
|
||||
|
Vendor notes receivable
|
$
|
1,170,079
|
||
|
Vendor advances receivable
|
(96,552
|
)
|
||
|
Accounts receivable
|
(20,965
|
)
|
||
|
Inventories
|
(509,447
|
)
|
||
|
Equipment
|
(543,115
|
)
|
||
|
Licensing Agreement
|
(125,000
|
)
|
||
|
Additional paid-in-capital
|
125,000
|
|||
|
Other receivables
|
(20,811
|
)
|
||
|
Accounts payable
|
20,811
|
|||
|
Insurance premium note payable
|
180,761
|
|||
|
Prepaid expense
|
(180,761
|
)
|
||
|
Common stock
|
604
|
|||
|
Additional paid-in-capital
|
(604
|
)
|
||
|
Prepaid interest
|
(46,188
|
)
|
||
|
Additional paid-in-capital
|
46,188
|
|||
|
Prepaid legal services
|
(224,000
|
)
|
||
|
Issuance of common stock
|
224,000
|
|||
|
Notes payable - related parties
|
200,000
|
|||
|
Issuance of common stock
|
750,000
|
|||
|
Patent acquisitions
|
(950,000
|
)
|
||
|
$
|
-
|
|||
| · |
The term of the agreement commenced on October 15, 2016. Ammo was granted exclusive worldwide rights to JJ’s image rights and any and all trademarks associated with JJ in connection with the marketing, promoting, advertising, sale and commercial exploitation of the Jesse James Branded Products (“Branded Products”).
|
| · |
Jesse James agreed to make himself available for certain promotional activities and to promote Branded Products through his own social media outlets. Ammo will reimburse JJ for any out-of-pocket expenses and reasonable travel expenses.
|
| · |
JJ was issued 100,000 shares of the Company’s common stock upon execution of the licensing agreement and can earn an additional 75,000 shares of common stock if certain gross sales are achieved ($15,000,000 gross sales to receive the total 75,000 shares).
|
| · |
The 100,000 shares of common stock were valued at $1.25 per share and the $125,000 was recognized as an asset and will be amortized over the initial sixty (60) month term of the licensing agreement.
|
| · |
Ammo agreed to pay JJ various royalty fees on the sale of ammunition and non-ammunition Branded Products.
|
| · |
The term of the agreement commenced on February 15th, 2017. Ammo was granted exclusive worldwide rights to JR’s image rights and any and all trademarks associated with JR in connection with the marketing, promoting, advertising, sale and commercial exploitation of the Jeff Rann Branded Products (“Branded Products”).
|
| · |
Jeff Rann agreed to make himself available for certain promotional activities and to promote Branded Products through his own social media outlets. Ammo will reimburse JR for any out-of-pocket expenses and reasonable travel expenses.
|
| · |
JR was issued 100,000 shares of the Company’s common stock upon execution of the licensing agreement and can earn an additional 75,000 shares of common stock if certain gross sales are achieved ($15,000,000 gross sales to receive the total 75,000 shares).
|
| · |
The 100,000 shares of common stock were valued at $1.25 per share and the $125,000 was recognized as an asset and will be amortized over the initial sixty (60) month term of the licensing agreement.
|
| · |
|
Advanced Tactical Armament Concepts, L.L.C. Notes Payable Purchased by Ammo
|
Amount
|
|||
|
Western Alliance Bank
|
$
|
1,910,993
|
||
|
Less: Allowance for uncollectible amounts
|
(360,993
|
)
|
||
|
1,550,000
|
||||
|
Mansfield, LLC
|
1,035,000
|
|||
|
$
|
2,585,000
|
|||
|
Vendor notes receivable
|
$
|
2,585,000
|
||
|
Vendor advances receivable
|
(96,552
|
)
|
||
|
Accounts receivable
|
(20,965
|
)
|
||
|
Inventories
|
(509,447
|
)
|
||
|
Equipment
|
(543,115
|
)
|
||
|
Loss on vendor notes receivable collectability
|
(1,414,921
|
)
|
||
|
$
|
0
|
|
2017
|
2016
|
|||||||
|
Finished product
|
$
|
969,843
|
$
|
0
|
||||
|
Raw materials
|
627,373
|
219,105
|
||||||
|
Work in process
|
11,177
|
0
|
||||||
|
$
|
1,608,393
|
$
|
219,105
|
|||||
| · |
require the licensing of all persons manufacturing, exporting, importing or selling firearms and ammunition as a business;
|
| · |
require serialization, labeling and tracking the acquisition and disposition of firearms, certain types of ammunition, and certain related products;
|
| · |
require background checks for purchasers of firearms;
|
| · |
impose waiting periods between the purchase of a firearm and the delivery of a firearm;
|
| · |
prohibit the sale of firearms to certain persons, such as those below a certain age and persons with criminal records;
|
| · |
regulate the use and storage of gun powder or other energetic materials;
|
| · |
regulate the interstate sale of certain firearms and ammunition;
|
| · |
prohibit the interstate mail-order sale of firearms;
|
| · |
regulate our employment of personnel with certain criminal convictions; and
|
| · |
restrict access to firearm or ammunition manufacturing facilities for certain individuals from other countries or with criminal convictions.
|
|
Exhibit
|
|
|
||
|
Number
|
|
Description of Exhibit
|
|
Filing
|
|
|
Incorporated by reference as Exhibits to the Form SB-2 filed on June 16, 1997.
|
|||
|
|
Filed with the SEC on March 20, 2017 as part of our Current Report on Form 8-K.
|
|||
|
|
Incorporated by reference as Exhibits to the Form SB-2 filed on June 16, 1997.
|
|||
|
|
Filed with SEC on March 20, 2017 as part of our Current Report on Form 8-K.
|
|||
|
|
Filed herewith.
|
|||
|
|
Filed herewith.
|
|||
|
|
Filed herewith.
|
|||
|
|
Filed herewith.
|
|||
|
101.INS*
|
|
XBRL Instance Document
|
|
Filed herewith.
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
Filed herewith.
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
Filed herewith.
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
Filed herewith.
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
Filed herewith.
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
Filed herewith.
|
|
|
AMMO, INC.
|
|
|
|
|
|
|
|
|
Dated: November 17, 2017
|
By:
|
/s/ Fred W. Wagenhals
|
|
|
|
|
Fred W. Wagenhals
President and Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
Dated: November 17, 2017
|
By:
|
/s/ Ron Shostack
|
|
|
|
|
Ron Shostack
Chief Financial Officer
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|